Sana Biotechnology, Inc. (SANA)
3.92
+0.03
(+0.77%)
USD |
NASDAQ |
Sep 03, 16:00
3.91
-0.01
(-0.26%)
After-Hours: 18:06
Sana Biotechnology Cash from Investing (Quarterly) : -87.52M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -87.52M |
| March 31, 2026 | 49.44M |
| December 31, 2025 | -16.50M |
| September 30, 2025 | -48.02M |
| June 30, 2025 | 7.68M |
| March 31, 2025 | 16.60M |
| December 31, 2024 | 47.09M |
| September 30, 2024 | 41.78M |
| June 30, 2024 | 5.818M |
| March 31, 2024 | -77.23M |
| December 31, 2023 | 15.31M |
| September 30, 2023 | 51.35M |
| June 30, 2023 | 42.63M |
| Date | Value |
|---|---|
| March 31, 2023 | 62.73M |
| December 31, 2022 | 88.43M |
| September 30, 2022 | 31.86M |
| June 30, 2022 | 77.73M |
| March 31, 2022 | 12.54M |
| December 31, 2021 | -73.66M |
| September 30, 2021 | -185.90M |
| June 30, 2021 | -35.32M |
| March 31, 2021 | 49.09M |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | 39.18M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Twist Bioscience Corp. | -10.20M |
| Beam Therapeutics, Inc. | -9.875M |
| Prime Medicine, Inc. | 24.03M |
| Intellia Therapeutics, Inc. | -141.57M |
| Moderna, Inc. | 329.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -32.79M |
| Cash from Financing (Quarterly) | 93.58M |
| Free Cash Flow | -135.06M |
| Free Cash Flow Per Share (Quarterly) | -0.1164 |
| Free Cash Flow to Equity (Quarterly) | -32.82M |
| Free Cash Flow to Firm (Quarterly) | -34.41M |
| Free Cash Flow Yield | -12.43% |